You are here: Industry Insights > Roche

News List

Roche joins quest to create closed loop insulin device pharmaphorum
July 27, 2017
Roche is teaming up with two medical tech companies to develop an automated insulin delivery system, the first steps towards an ‘artificial pancreas.’
Roche hails 4 year NICE access deal for Gazyvaro pharmaphorum
July 27, 2017
NICE has agreed a deal with Roche on its new follicular lymphoma treatment Gazyvaro, giving the drug up to four years to prove its value to patients.
NICE recommends Roche’s blood cancer drug via Cancer Drugs Fund for rituximab refractory follicular firstwordpharma
July 27, 2017
Gazyvaro is one of the first in a series of innovative therapies that are expected to be considered by NICE this year via the new appraisal process for cancer medicines, and it could make a significant difference to patient outcomes across England.
Roche antibody becomes first of its kind authorised for blood cancer pharmafile
July 27, 2017
NICE has announced its decision to make Roche’s Gazyvaro available via the Cancer Drugs Fund (CDF) in combination with chemotherapy for the treatment of follicular lymphoma
Roche’s Ocrevus receives TGA approval for RMS and PPMS treatment in Australia pharmaceutical-technology
July 19, 2017
The Australian Therapeutic Goods Administration (TGA) has granted approval for Roche’s Ocrevus (ocrelizumab) for the treatment of relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS).
Oncology Drug Market Size to Approach USD 200 Billion: Changing Giants, Same Roche en-cphi.cn
July 14, 2017
The authoritative research report on the pharmaceutical industry recently issued by EvaluatePharma and IMS Health has made in-depth analysis and forecast for the pharmaceutical industry and global oncology drug development trends.
Positive phase III results for Roche’s emicizumab in haemophilia A published in The New England Jour worldpharmanews
July 13, 2017
Roche today announced that data from HAVEN 1, a phase III study evaluating once-weekly subcutaneous emicizumab prophylaxis (preventative) in adults and adolescents with haemophilia A with inhibitors, were published in The New England Journal of Medicine (
Roche acquires mySugr to form a leading open platform for digital diabetes management worldpharmanews
July 04, 2017
Roche (SIX: RO, ROG; OTCQX: RHHBY) and mySugr have signed an agreement under which Roche acquired all shares of mySugr GmbH.
Roche acquires mySugr to form a leading open platform for digital diabetes management worldpharmanews
July 04, 2017
Roche (SIX: RO, ROG; OTCQX: RHHBY) and mySugr have signed an agreement under which Roche acquired all shares of mySugr GmbH.
European Commission approves Roche’s new Esbriet tablet formulation for IPF pharmaceutical-technology
July 03, 2017
The European Commission (EC) has approved a new tablet formulation of Swiss pharmaceutical company Roche’s Esbriet (pirfenidone) to treat patients with mild to moderate idiopathic pulmonary fibrosis (IPF).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page